Advertisement

Topics

Global Prepacked Chromatography ColumnsMarket 2015-2019 - Analysis and Forecasts for the $2.1 Billion Industry

20:00 EDT 21 Jul 2015 | Globe Newswire

Dublin, July 22, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/bp4gw3/prepacked) has announced the addition of the "Prepacked Chromatography Columns Market by Type (1-100 mL, 100-1000 mL, 1L), End User (Academic, Hospitals, Cosmetics, Environmental Biotechnology, Food & Beverages, Nutraceuticals, Pharmaceuticals) & Geography - Global Forecast to 2019" report to their offering.

This report studies the global prepacked chromatography columns market during the forecast period (2014-2019). The market is estimated at $1.42 Billion in 2014, and is projected to reach $2.11 Billion by 2019, at a CAGR of 8.4% from 2014 to 2019.

Prepacked columns are pre-filled with the stationary phase and can directly be attached to chromatographic systems. The packing differs for analytical columns and preparative columns. Prepacked columns exhibit minimal variations and are uniform in nature. These columns are used for early method development to optimize the column packing.

In 2014, North America is projected to dominate the global market, followed by Asia-Pacific and Europe. North America also occupies the highest share in the 1-100 mL segment of the global market.

Increasing demand for purification of antibodies, recombinant proteins and vaccines, and virus titer reduction validation, in addition to process development and affordable purification of biological drugs are significant major factors propelling the overall demand of the global market.

On the other hand the market is currently restricted by technological limitations of the column size. The large-scale columns (45 cm-60 cm in diameter) are being highly commercialized and developed, thereby increasing its market potential in the chromatography columns segment. Prepacked columns beyond 30 cm diameter size are generally unavailable, which in turn creates a sudden surge in the demand for columns greater than 45 cm-60 cm in diameter. Larger prepacked columns are being extensively developed as it offers technical, economic, and logistical advantages in comparison to other prepacked columns.

Key Topics Covered:


1 Introduction

2 Research Methodology

3 Executive Summary

4 Market Overview

5 By Type

6 By Geography

7 Competitive Landscape

8 Company Profiles

- Agilent Technologies
- Atoll GmbH
- Bio-Rad Laboratories, Inc.
- Emd Millipore/ Merck Millipore (A Division of Merck KggA)
- Ge Healthcare
- Pall Corporation
- Phenomenex, Inc.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation

For more information visit http://www.researchandmarkets.com/research/bp4gw3/prepacked



CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Medical Devices

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Global Prepacked Chromatography ColumnsMarket 2015-2019 - Analysis and Forecasts for the $2.1 Billion Industry"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...